Dr Andreas Calatzis

graduated from the Medical School of the Technische Universitaet Munich in 1998.

In the period of 1998-1999 he was research assistant at the Institute for Experimental Oncology and Therapeutic Research (Technische Universitaet Munich) in the laboratory of Professor Stemberger and Professor Haas. Since 1999 he has a scientific appointment at the Department for Hemostasis and Transfusion Medicine under director Professor Schramm ( Ludwig-Maximilians University , Munich ). He is a member of the German Society of Thrombosis and Haemostasis (GTH).

The main emphasis of the work of Dr. Calatzis is the development and evaluation of diagnostic methods.

In the period of 1995-1998, together with the physicist Pablo Fritzsche, he developed a new thromboelastographic device, the ROTEM analyzer, which is today used in more then 400 installations worldwide. For this development he was awarded the 2. Price of the student competition of the German Society for Biomedical Technology (29 th Annual Meeting in 1995) and the Young Researcher Award of the European Society for Surgical Research (31 st Annual meeting in 1996).

In 1999-2004, together with the Swiss company Pentapharm, he developed the Prothrombinase induced Clotting test, a laboratory reagent for the determination of anticoagulant activity, which is currently introduced into the market in Germany and Austria . For this development he was awarded a poster price on the 7 th International Symposium on Thromboembolic Diseases (2000).

Since 2003 he has been heading a working group which develops and introduces a new platelet function analyzer, the Multiplate device, which is based on impedance aggregometry.

He is author and co-author of several publications.